Product name: Posaconazole
Other name: HYDROXYPROPYL]-2,4-DIHYDRO-3H-1,2,4-TRIAZOL-3-ONE; Noxafil; Pos; Posconazole; Pcz; D-threo-Pentitol,2,5-anhydro-1,3,4-trideoxy-2-C-(2,4-difluorophenyl)-4-[[4-[4-[4-[1-[(1S,2S)-1-ethyl-2-hydroxypropyl]-1,5-dihydro-5-oxo-4H-1,2,4-triazol-4-yl]phenyl]-1-piperazinyl]phenoxy]methyl]-1-(1H-1,2,4-triazol-1-yl)-
Wuhan port sails
White solid, density: 1.36 g/cm³.
- Pharmaceutical intermediates
It is a derivative of itraconazole, is a second-generation triazole antifungal drug marketed by the FDA in 2006. Its pharmacological effects are similar to those of azole drugs, but it has a stronger inhibitory effect on sterol C14 demethylation than itraconazole, especially on aspergillus aspergillus. This product is suitable for fungal disease caused by candida, cryptococcus, respiratory, digestive tract, urinary tract mycosis, peritonitis, meningitis and so on.